SIBEPRENLIMAB

UNII:	GHX28QZ7DD
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SIBEPRENLIMAB
GSRS Full Record:	GHX28QZ7DD i

2382896-07-1
Immunogloabulin G2-kappa, anti-[Homo sapiens TNFSF13 (tumor necrosis factor (TNF) superfamily member 13, APRIL, CD256)], humanized monoclonal antibody; gamma2 heavy chain humanized (1-446) [VH (Homo sapiens IGHV1-46*01 (85.7%) -(IGHD) -IGHJ4*01 (100%)) CDR-IMGT [8.8.13] (26-33.51-58.97-109) (1-120) -Homo sapiens IGHG2*01 (100%), G2m.. CH2 V45.1 (CH1 (121-218), hinge 1-12 (219-230), CH2 V45.1 (281) (231-339), CH3 (340-444), CHS (445-446)) (121-446)], (134-218')-disulfide with kappa light chain humanized (1'-218') [V-KAPPA (Homo sapiens IGKV3-15*01 (85.9%) -IGKJ4*01 (100%)) CDR-IMGT [10.3.9] (27-36.54-56.93-101) (1'-111') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (157), V101 (195) (112'-218')]; dimer (222-222'':223-223'':226-226”:229-229”)-tetrakisdisulfide, produced in a Chinese hamster ovary (CHO)-K1 derived cell line, glycoform alfa
Immunoglobulin G2, anti-(human proliferation-inducing ligand protein) (human monoclonal VIS649 γ2-chain), disulfide with human monoclonal VIS649 κ-chain, dimer
SIBEPRENLIMAB [USAN]
Sibeprenlimab [WHO-DD]
Sibeprenlimab-SZSI
VIS-649
VIS649
VOYXACT
sibeprenlimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SIBEPRENLIMAB

Synonyms and Mappings

Resources